CME GROUP INCInsider Trading & SEC Form 4 Analysis
Institutional analysis of internal capital flows based on SEC Form 4 filings.
Automated_Intelligence_Report :: CME
Algorithmic analysis of recent insider trading activity for CME reveals a bearish posture among the C-suite and board members. Based on the latest SEC Form 4 filings, we have tracked capital events executed by 27 distinct corporate insiders. The aggregate nominal exposure during this reporting cycle reached $108.56M.
Market dynamics show a negative net capital flow of $29.79M when isolating open-market purchases versus open-market sales. Interestingly, a significant portion of the total volume is driven by the exercise of options or grants rather than open-market transactions, suggesting that insiders are currently prioritizing compensation-based equity accumulation or tax-related liquidation over voluntary portfolio rebalancing.
From a microstructural perspective, the landscape is fragmented. SHEPARD WILLIAM R led the buying pressure, while DUFFY TERRENCE A registered the largest single offload of shares. Continuous monitoring of these Tier-1 actors is essential, as their liquidity decisions often precede material corporate events or reflect an informed, asymmetric perspective on the future performance of CME.
$108.56M
USD NOMINAL VALUE27
UNIQUE C-SUITE ENTITIES2026.05.18
ISO_8601 FORMATAutomated_Queries :: Frequently Asked Questions
>Who is currently buying CME stock?
Based on the latest SEC Form 4 filings, SHEPARD WILLIAM R (Director) has been actively acquiring shares. The total recent insider buying volume stands at $0.58M.
>Are CME insiders selling their shares?
Yes, we have tracked $30.38M in recent insider liquidations. The most notable recent seller is DUFFY TERRENCE A, who executed the largest single offload.
>What is the overall insider sentiment for CME?
The short-term structural capital flow indicates a BEARISH sentiment, with a net flow of $29.79M generated by 27 active C-Suite entities.